FDA Outlines Views Of Clinical Trials Without Placebo Groups

The U.S. Food and Drug Administration released draft guidance Wednesday on a type of clinical trial that would compare patients receiving an investigational drug to patients outside the trial, pointing to...

Already a subscriber? Click here to view full article